CompanyNasdaqWestminster, CO
TriSalus Life Sciences, Inc
TriSalus develops oncology devices and immunotherapy for solid tumors.
10-QNov 10Latest SEC filing
Form DMay 8$22M sold
November 2026
Sign inSign inTriSalus develops oncology devices and immunotherapy for solid tumors.